2021 annual financial data
Relmada Therapeutics 2021 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -125,703,492 USD and net income was -125,751,809 USD.
Operating cash flow was -91,873,395 USD.
Get free Relmada Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -125,703,492 USD
- Net income
- -125,751,809 USD
- Operating cash flow
- -91,873,395 USD
Explore related company data
View all 2021 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Relmada Therapeutics financial years